[1]
S. T. Sutanto, R. Sinto, A. Pasaribu, and S. Shakinah, “Molnupiravir and Nirmatrelvir/Ritonavir: The New Available Antiviral Options for COVID-19”, Acta Med Indones, vol. 54, no. 4, p. 638, Jan. 2023.